1. Home
  2. GRNQ vs NCNA Comparison

GRNQ vs NCNA Comparison

Compare GRNQ & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenpro Capital Corp.

GRNQ

Greenpro Capital Corp.

HOLD

Current Price

$1.75

Market Cap

16.6M

Sector

Technology

ML Signal

HOLD

Logo NuCana plc

NCNA

NuCana plc

HOLD

Current Price

$2.24

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRNQ
NCNA
Founded
2013
1997
Country
Malaysia
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.6M
13.8M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
GRNQ
NCNA
Price
$1.75
$2.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.1K
68.3K
Earning Date
11-13-2025
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,110,208.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.04
N/A
52 Week Low
$0.84
$2.07
52 Week High
$2.50
$268.00

Technical Indicators

Market Signals
Indicator
GRNQ
NCNA
Relative Strength Index (RSI) 42.26 29.00
Support Level $1.75 $2.08
Resistance Level $1.88 $2.26
Average True Range (ATR) 0.07 0.18
MACD -0.02 -0.03
Stochastic Oscillator 0.00 9.42

Price Performance

Historical Comparison
GRNQ
NCNA

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Share on Social Networks: